Levels of willingness to undergo BRCA1/2 testing and preventive measures for breast and ovarian cancer risk, however, provide some useful indicators of public awareness regarding testing and the potential demand for information about testing. The gene discussed is BRCA1; the disease is ovarian carcinoma.